Danaher Corporation vs Abrdn Physical Platinum Shares ETF — how do they compare? Danaher Corporation trades at $200.49 (market cap $140.88B), while Abrdn Physical Platinum Shares ETF trades at $14.81. The key difference: Danaher Corporation pays a 0.8% dividend while Abrdn Physical Platinum Shares ETF pays none, and Danaher Corporation is trading nearer its 52-week high, Abrdn Physical Platinum Shares ETF nearer its low. Which is the better fit depends on your goals.
| DHR | PPLT | |
|---|---|---|
Market Cap | $140.88B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $242.05 | $25.23 |
52-Week Low | $161.91 | $11.78 |
Enterprise Value | $153.66B | — |
Dividend Yield | 0.8% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PPLT trades at $14.52, down 1.69% with a bearish technical outlook showing 15 sell signals versus 0 buy signals. The ETF recently underwent a 1:10 stock split effective May 18, 2026, which adjusted share count without changing the fund's underlying value. Platinum has underperformed other precious metals recently, creating potential catch-up trade opportunities according to market commentary.
The outlook remains cautious as platinum lags gold's rally, though some analysts see long-term potential. Key risks include precious metals volatility and correlation dynamics. Recent downgrades to 'Hold' suggest limited near-term upside after PPLT's 84-100% returns over the past year, requiring careful entry timing for new positions.
Trailing returns across standard periods
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Through a series of mergers, acquisitions, and divestitures, including the Fortive separation in 2016, Danaher now focuses primarily on manufacturing scientific instruments and consumables in three segments: life sciences, diagnostics, and environmental and applied solutions. In late 2019, Danaher separated from its dental business through an initial public offering process, and in early 2020, it acquired GE's Biopharma business, now called Cytiva, which added to its life sciences segment.
Read more on DHR →PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →